Follow The Filings

PTCT

Earnings company data as of 4:45 AM ET 10/16

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 0.15 — —
Rev — — —

Insider trades

Open-market buys and sales by PTCT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PTCT insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $51.2M sold by 12 insiders under 10b5-1 plans
  1. Michael Schmertzler Director
    Planned sale
    $149K 2,500 shares at $59.61 0.2% of stake
    Traded Oct 14 Filed Oct 16
    ↗
  2. Mark Elliott Boulding Exec. VP and CLO
    Planned sale
    $12K 192 shares at $64.26 0.2% of stake
    Traded Oct 9 Filed Oct 13
    ↗
  3. Michael Schmertzler Director
    Planned sale
    $158K 2,500 shares at $63.39 0.2% of stake
    Traded Oct 7 Filed Oct 9
    ↗
  4. Mark Elliott Boulding Exec. VP and CLO
    Planned sale
    $133K 2,073 shares at $64.06 1.9% of stake
    Traded Oct 5–6 Filed Oct 7
    ↗
  5. Glenn Steele Jr. MD PHD Director
    Planned sale
    $782K 12,000 shares at $65.16 35% of stake
    Traded Sep 30 Filed Oct 2
    ↗
  6. Michael Schmertzler Director
    Planned sale
    $1.3M 20,000 shares at $67.49 1.5% of stake
    Traded Sep 16–17 Filed Sep 18
    ↗
  7. Michael Schmertzler Director
    Planned sale
    $1.4M 20,000 shares at $67.59 1.5% of stake
    Traded Sep 9–10 Filed Sep 11
    ↗
  8. Michael Schmertzler Director
    Planned sale
    $1.8M 25,000 shares at $72.26 1.8% of stake
    Traded Aug 26–27 Filed Aug 28
    ↗
  9. Michael Schmertzler Director
    Planned sale
    $1.8M 25,000 shares at $72.22 1.8% of stake
    Traded Aug 19–20 Filed Aug 21
    ↗
  10. Mark Elliott Boulding Exec. VP and CLO
    Planned sale
    $204K 2,813 shares at $72.57 2.6% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  11. Mary L. Smith Director
    Planned sale
    $1.4M 15,834 shares at $90.00 42% of stake
    Traded Jul 9 Filed Jul 13
    ↗
  12. Neil Gregory Almstead Chief Technical Ops Officer
    Planned sale
    $222K 2,464 shares at $90.25 3.9% of stake
    Traded Jul 9 Filed Jul 13
    ↗
  13. Mark Elliott Boulding Exec. VP and CLO
    Planned sale
    $432K 5,079 shares at $85.08 4.6% of stake
    Traded Jul 6 Filed Jul 8
    ↗
  14. Neil Gregory Almstead Chief Technical Ops Officer
    Planned sale
    $4.1M 46,774 shares at $87.52 44% of stake
    Traded Jul 6–7 Filed Jul 8
    ↗
  15. Neil Gregory Almstead Chief Technical Ops Officer
    Planned sale
    $693K 8,130 shares at $85.26 12% of stake
    Traded Jun 26 Filed Jun 30
    ↗

Also filed in the last 12 months, not counted as buying or selling: 67 option exercises, 38 sales to cover taxes, 24 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,3.02,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.